McKeating JA - Search Results

1

Time-of-Day Variation in SARS-CoV-2 RNA Levels during the Second Wave of COVID-19.

Zhuang X, Wang W, Borrmann H, Balfe P, Matthews PC, Eyre DW, Klerman EB, McKeating JA. Zhuang X, et al. Among authors: mckeating ja. Viruses. 2022 Aug 5;14(8):1728. doi: 10.3390/v14081728. Viruses. 2022. PMID: 36016350 Free PMC article.

2

The role of the viral glycoprotein in HIV-1 persistence.

McKeating JA, Balfe P. McKeating JA, et al. Immunol Lett. 1999 Jan;65(1-2):63-70. doi: 10.1016/s0165-2478(98)00126-6. Immunol Lett. 1999. PMID: 10065629 Review.

3

Scavenger receptor BI and BII expression levels modulate hepatitis C virus infectivity.

Grove J, Huby T, Stamataki Z, Vanwolleghem T, Meuleman P, Farquhar M, Schwarz A, Moreau M, Owen JS, Leroux-Roels G, Balfe P, McKeating JA. Grove J, et al. Among authors: mckeating ja. J Virol. 2007 Apr;81(7):3162-9. doi: 10.1128/JVI.02356-06. Epub 2007 Jan 10. J Virol. 2007. PMID: 17215280 Free PMC article.

4

Hepatitis C virus envelope glycoprotein immunization of rodents elicits cross-reactive neutralizing antibodies.

Stamataki Z, Coates S, Evans MJ, Wininger M, Crawford K, Dong C, Fong YL, Chien D, Abrignani S, Balfe P, Rice CM, McKeating JA, Houghton M. Stamataki Z, et al. Among authors: mckeating ja. Vaccine. 2007 Nov 7;25(45):7773-84. doi: 10.1016/j.vaccine.2007.08.053. Epub 2007 Sep 14. Vaccine. 2007. PMID: 17919789

5

Effect of cell polarization on hepatitis C virus entry.

Mee CJ, Grove J, Harris HJ, Hu K, Balfe P, McKeating JA. Mee CJ, et al. Among authors: mckeating ja. J Virol. 2008 Jan;82(1):461-70. doi: 10.1128/JVI.01894-07. Epub 2007 Oct 24. J Virol. 2008. PMID: 17959672 Free PMC article.

6

Hepatitis C virus receptor expression in normal and diseased liver tissue.

Reynolds GM, Harris HJ, Jennings A, Hu K, Grove J, Lalor PF, Adams DH, Balfe P, Hübscher SG, McKeating JA. Reynolds GM, et al. Among authors: mckeating ja. Hepatology. 2008 Feb;47(2):418-27. doi: 10.1002/hep.22028. Hepatology. 2008. PMID: 18085708

7

Hepatitis C virus entry and neutralization.

Stamataki Z, Grove J, Balfe P, McKeating JA. Stamataki Z, et al. Among authors: mckeating ja. Clin Liver Dis. 2008 Aug;12(3):693-712, x. doi: 10.1016/j.cld.2008.03.008. Clin Liver Dis. 2008. PMID: 18625435 Review.

8

Identification of a residue in hepatitis C virus E2 glycoprotein that determines scavenger receptor BI and CD81 receptor dependency and sensitivity to neutralizing antibodies.

Grove J, Nielsen S, Zhong J, Bassendine MF, Drummer HE, Balfe P, McKeating JA. Grove J, et al. Among authors: mckeating ja. J Virol. 2008 Dec;82(24):12020-9. doi: 10.1128/JVI.01569-08. Epub 2008 Oct 1. J Virol. 2008. PMID: 18829747 Free PMC article.

9

Hepatitis C virus association with peripheral blood B lymphocytes potentiates viral infection of liver-derived hepatoma cells.

Stamataki Z, Shannon-Lowe C, Shaw J, Mutimer D, Rickinson AB, Gordon J, Adams DH, Balfe P, McKeating JA. Stamataki Z, et al. Among authors: mckeating ja. Blood. 2009 Jan 15;113(3):585-93. doi: 10.1182/blood-2008-05-158824. Epub 2008 Oct 6. Blood. 2009. PMID: 18838615 Free PMC article.

10

Polarization restricts hepatitis C virus entry into HepG2 hepatoma cells.

Mee CJ, Harris HJ, Farquhar MJ, Wilson G, Reynolds G, Davis C, van IJzendoorn SC, Balfe P, McKeating JA. Mee CJ, et al. Among authors: mckeating ja. J Virol. 2009 Jun;83(12):6211-21. doi: 10.1128/JVI.00246-09. Epub 2009 Apr 8. J Virol. 2009. PMID: 19357163 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

267 results

Search Page

Filters